REVISTA GUIA FARMACEUTICA Nº129

Page 21

Nuevos productos y presentaciones del mes PRODUCTO [LABORATORIO]

Presentación

P.V.Unit.$ P.V.P.$

• A• ACROVASTIN [ACROMAX] (Atorvastatina) 3 Comp. 40 mg x 30 2.40 72 AMPICILINA GM [G.M.] 3 Vial 1 g x 10 1.82 18.20 [BIODERMA] ATODERM PP ANTIRECIDIVE 3 Tubo 200 ml 35.00 35.00 [G.M.] ATORVASTATINA GM 3 Tab. 10 mg x 10 0.98 9.80 1.00 10.00 3 Tab. 20 mg x 10 Blue Cap 3 Crema 50 g 3 Shampoo 150 ml 3 Spray 100 ml BROMHEXINA GM 3 Jbe. 8 mg/5 ml x 120 ml

• B•

[Catalys is Beta] 24,19 24,19 22,18 22,18 30,91 30,91 [G.M.] 5.22 5.22

• C•

Cefulam [Lamosan] 3 Jbe. 125 mg/5 ml x 70 ml 10,20 10,20 3 Jbe. 250 mg/5 ml x 75 ml 12,96 12,96 3 Tab. 500 mg x 10 1,45 14,48 3 Tab. 250 mg x 10 0,80 8,00 Cetaphil Restoraderm hidratant [GALDERMA] 3 Fco. 295 ml 37,81 37,81 Cetaphil Restoraderm Limpiador Co [GALDERMA] 3 Fco. 295 ml 27,53 27,53 Cicatrix [Catalys is Beta] 3 Crema 30 ml 40,32 40,32 Clarimed [Magma] 3 Susp. 250 mg/5 ml 14,72 14,72 3 Tab. 500 mg x 10 1,21 12,10 Cloruro de Sodio al 9 % Magma [Magma] 3 Sol. Iny. 2,75 2,75 • D• DEGRALER (Levocetirizina) 3 Jbe. Forte 5 mg/5 ml x 100 ml DENTURE KIDS 3 Cepillo dental DESLER (Desloratadina) 3 Jbe. 0.5 mg/1 ml x 120 ml DIME (Policresuleno) 3 Gel 50% x 50 g Dolfemin 3 Tab. 400 mg x 20 Dolocuraflex 3 Sobres 15 mg x 15 3 Sobres 15 mg x 30 DOLVEX (Nimesulida) 3 Gel 3% x 30 g • E• ERALDOR NF (Paracetamol o Acetaminofén) 3 Tab. x 12 Eucerin HYALURON FILLER 3 Concentrado 30 ml Eucerin SUN CLEAR 3 Spray FPS 50 x 200 ml

[BAGÓ] 19.90 19.90 [LAMOSAN] 4.90 4.90 [GALENO] 12.00

12.00 [ROCNARF]

12 12 [Italfarma] 0,50 10,00 [Medicamenta] 2,00 30,00 2,00 60,00 [ROCNARF] 5.10

5.10

[SCHERING PLOUGH] 0.30 64.20 28.30

PRODUCTO [LABORATORIO]

Presentación

FLEBODIA (Diosmina) 3 Comp. x 30

P.V.Unit.$ P.V.P.$

• F•

1.14

Flimox (Montelukast) 3 Comp. 10 mg x 30 3 Comp. Mastic. 5 mg x 30 3 Comp. Mastic. 4 mg x 30 HAPECO (Multivitaminas) 3 Gotas x 30 ml HEPASIL Q (Silimarina+Coenzima Q10) 3 Cáps. x 24 LaLEVo (Levofloxacino) 3 Comp. 750 mg x 5 LORATADINA GM 3 Jbe. 5 mg/5 ml x 100 ml 3 Tab. 10 mg x 20 Martesia 3 Cáps. 75 mg x 28 3 Cáps. 150 mg x 28 3 Cáps. 300 mg x 28 3 Cáps. 25 mg x 28 Melanil 3 Crema 50 ml Metformina Medley 3 Tab. 850 mg x 30 MUCOXIN JR (Ambroxol+Loratadina) 3 Jbe. 120 ml MUMFER (Hierro) 3 Gotas 15 ml x 1 3 Tab. x 30 Natalac Femenine 3 Fco. 110 ml 3 Fco. 220 ml

[INNOTECH]

• H•

28,50 15,90 12,90

[ROCNARF] 4 4 [ROCNARF] 0.40

• L•

10 0.26 • M•

9.60

[Acromax] 2,40

12,00 [G.M.] 10 5.16

[Roemmers] 0,95 26,60 1,50 42,00 2,00 56,00 0,75 21,00 [Catalys is Beta] 56,45 56,45 [SANOFI AVENTIS] 0,25 7,36 [ROCNARF] 5.00 5.00 [GLENMARK] 6,03 0,51

• N•

Presentación

P.V.Unit.$ P.V.P.$

Natalac INFANTIL 3 Fco. 110 ml 3 Fco. 220 ml

[Marcor Pharma S.A.] 2,98 2,98 4,78 4,78

34.20

[Acromax] 0,95 0,53 0,43

PRODUCTO [LABORATORIO]

6,03 15,30

[Marcor Pharma S.A.] 2,98 2,98 4,78 4,78

Norcuron 3 Amp. 4 mg + solvente 1 ml x 5 ODONTOSEPTIC (Clorhexidina,Xilitol) 3 Fco. 1 lt

• O•

[Schering Plough] 4,74 23,70 [LAMOSAN] 4.80

4.80

• P• PROFEM [G.M.] 3 Tab. 600 mg x 10 0.69 6.90 0.72 7.20 3 Tab. 800 mg x 10

Relcer 3 Tab. x 20

• R•

[Glenmark] 0,30 6,00

• S• SINGRIPAL [ITALFARMA] (Clorfeniramina, Paracetamol o Acetaminofén, Pseudoefedrina) 3 Sobres x 30 0.29 14.84 Sinresor [Bagó] (Ácido Zolendrónico) 3 Amp. 4 mg/5 ml x 1 130,84 130,84 SULAMP [GALENO] (Saltamicina) 3 Susp. 500 mg/5 ml x 120 ml 25.20 25.20 Soluna [Magma] 3 Sol. iny. 1 ml x 5 0,97 4,84 Sulfacif [Cifsa] 3 Tab. x 100 0,17 16,73 TIOCOLFEM 3 Tab. 4 mg/400 mg x 15 Valdoxan 3 Comp. Recub. 27 mg x 28 XOLOF (Tobramicina) 3 Ung. Oft. 3.5 g XOLOF-D (Dexametasona,Tobramicina) 3 Ung. Oft. 3.5 g

• T• 1,05

[GALENO] 15.80

1,86

[Servier] 52,08

• V•

• X•

[NICOLICH/SAVAL] 8,68 8,68 [NICOLICH/SAVAL] 9,47

9,47

3.60 [BDF] 64.20 [BDF] 28.30

19


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.
REVISTA GUIA FARMACEUTICA Nº129 by Edifarm & Cía. - Issuu